Late filing
elevated
Filing comparison
Oncotelic Therapeutics, Inc. told the SEC it could not file its annual report on time
Does not expect a significant change in results. Filed on the statutory due date.
The Company is working on and unable to compile the necessary financial information required to prepare a complete filing. Thus, the Company would be unable to file the annual report in a timely manner without unreasonable effort or expense. The Company expects to file within the extension period.
Evidence
- Anticipates significant change
- No
- Days past due date
- 0
- Other periodic reports filed
- Yes
- Routine
- No
- Severity
- elevated
- Source
- Form 12b-25 (notification of late filing)
- Stated reason
- The Company is working on and unable to compile the necessary financial information required to prepare a complete filing. Thus, the Company would be unable to file the annual report in a timely manner without unreasonable effort or expense. The Company expects to file within the extension period.
- Why
- The company told the SEC it could not file a periodic report on time, using Form 12b-25.